Investment Focus
Artificial Intelligence
Autonomous Vehicles
Fintech
DNA Sequencing
Robotics
Overview
- Type: Active Options-Overlay
- Typical # of Holdings: 4
- Inception: Oct. 2025
- Portfolio Manager: Catherine Wood
-
Analysts:
Collective Team
Strategy Description
This is an actively managed options-overlay strategy that, for rolling 12-month periods from inception date (each, an “Outcome Period”) seeks to provide investors with a defined risk-return profile, before fees and expenses. Specifically, the strategy is structured to limit downside participation to approximately 50% of any decline in the share price of the reference asset, the ARK Disruptive Innovation ETF (ARKK), measured from its value at the beginning of each Outcome Period. At the same time, the strategy is structured to provide maximum participation in ARK Disruptive Innovation ETF's upside above a predefined hurdle rate of approximately 5%.
Availability
| Strategy | ETF | Managed Account |
ARK DIET Buffer |
The content presented does not constitute investment advice, should not be used as the basis for any investment decision, and does not purport to provide any legal, tax or accounting advice. Certain of the statements contained on this website may be statements of future expectations and other forward-looking statements that are based on ARK’s current views and assumptions, and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Please remember that there are inherent risks involved with investing in the markets, and your investments may be worth more or less than your initial investment upon redemption. There is no guarantee that ARK’s objectives will be achieved. Further, there is no assurance that any strategies, methods, sectors, or any investment programs herein were or will prove to be profitable, or that any investment recommendations or decisions we make in the future will be profitable for any investor or client. Professional money management is not suitable for all investors. For full disclosures, please go to our Terms & Conditions page.